Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

University of Medicine and Dentistry of New Jersey

Status and phase: Terminated; Phase 2

Conditions: Psoriasis; Eczema

Treatments: Drug: Placebo Application; Drug: Neuroskin Forte

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00143819

5494

Details and patient eligibility

About

The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.

Full description

Subjects will apply study drug and placebo sprays 3 times a day to the assigned, randomized sides of the body. They are allowed to continue using prescription medications, but not moisturizers. Assessments will be performed every other week. Total duration of the study is 10 weeks (8 weeks of treatment and a follow-up visit 2 weeks later).

Enrollment: 13 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Must be at least 18 years of age
• Have psoriasis or eczema on both sides of the body, with a pair of roughly symmetrical bilateral "target" lesions at least 1.5 cm in diameter

Exclusion Criteria

• Inability to understand the consent form and/or comply with the requirements of this study
• Use of moisturizers/emollients within 2 days of beginning study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

13 participants in 2 patient groups, including a placebo group

1

Active Comparator group

Description:

bilateral comparison

Treatment:

Drug: Neuroskin Forte

2

Placebo Comparator group

Description:

bilateral comparison

Treatment:

Drug: Placebo Application